Condition: Heart Failure with Preserved Ejection Fraction · Heart Failure, Diastolic · Chronic Heart Failure · Sponsor: Erasmus Medical Center
The primary objective is to investigate the association between temporal evolutions of blood biomarkers and clinical adverse events, in order to produce a dynamic, individual, and accurate prediction model for patients with HFpEF. Moreover several secondary objectives will be investigated.
This description comes directly from the study's public registry record.
Isabella Kardys, Prof. · +31650032051 · i.kardys@erasmusmc.nl
Always discuss trial participation with your own doctor first.
| Noordwest Ziekenhuisgroep | Alkmaar, North Holland, Netherlands | Recruiting |
| Amsterdam UMC | Amsterdam, North Holland, Netherlands | Recruiting |
| OLVG Ziekenhuis | Amsterdam, North Holland, Netherlands | Recruiting |
| Franciscus Gasthuis & Vlietland Ziekenhuis | Rotterdam, South Holland, Netherlands | Recruiting |
| Erasmus MC | Rotterdam, South Holland, Netherlands | Recruiting |
| Ikazia Ziekenhuis | Rotterdam, South Holland, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06785506